ANAPTYSBIO INC (ANAB) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 220 transactions totaling $172.3M, demonstrating a bullish sentiment with $20.7M in net insider flow. The most recent transaction on Jan 8, 2026 involved a sale of 14,281 shares valued at $638.5K.
No significant insider buying has been recorded for ANAB in the recent period.
No significant insider selling has been recorded for ANAB in the recent period.
Based on recent SEC filings, insider sentiment for ANAB is bullish with an Insider Alignment Score of 56/100 and a net flow of $20.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ANAPTYSBIO INC (ANAB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading ANAB stock, having executed 220 transactions in the past 90 days. The most active insider is Capital, Llc Ecor1 (Executive), who has made 6 transactions totaling $102.3M.
Get notified when executives and directors at ANAB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | Faga Daniel | Executive | Sale | 14,281 | $44.71 | $638.5K | Large |
| Jan 8, 2026 | J. Loumeau Eric | CHIEF LEGAL OFFICER | Sale | 2,210 | $44.71 | $98.8K | |
| Jan 8, 2026 | Mulroy Dennis | CHIEF FINANCIAL OFFICER | Sale | 2,515 | $44.71 | $112.4K | C-Suite |
| Jan 8, 2026 | F. Lizzul Paul | Chief Medical Officer | Sale | 3,650 | $44.71 | $163.2K | |
| Jan 7, 2026 | Faga Daniel | Executive | Option Exercise | 26,838 | $N/A | $0 | |
| Jan 7, 2026 | Faga Daniel | Executive | Option Exercise | 26,838 | $N/A | $0 | |
| Jan 7, 2026 | J. Loumeau Eric | CHIEF LEGAL OFFICER | Option Exercise | 5,888 | $N/A | $0 | |
| Jan 7, 2026 | J. Loumeau Eric | CHIEF LEGAL OFFICER | Option Exercise | 5,888 | $N/A | $0 | |
| Jan 7, 2026 | Mulroy Dennis | CHIEF FINANCIAL OFFICER | Option Exercise | 6,700 | $N/A | $0 | C-Suite |
| Jan 7, 2026 | Mulroy Dennis | CHIEF FINANCIAL OFFICER | Option Exercise | 6,700 | $N/A | $0 | C-Suite |
| Jan 7, 2026 | F. Lizzul Paul | Chief Medical Officer | Option Exercise | 8,525 | $N/A | $0 | |
| Jan 7, 2026 | F. Lizzul Paul | Chief Medical Officer | Option Exercise | 8,525 | $N/A | $0 | |
| Jan 5, 2026 | F. Lizzul Paul | Chief Medical Officer | Sale | 4,219 | $43.26 | $182.5K | |
| Jan 5, 2026 | Mulroy Dennis | CHIEF FINANCIAL OFFICER | Sale | 3,363 | $43.26 | $145.5K | C-Suite |
| Jan 5, 2026 | Faga Daniel | Executive | Sale | 15,309 | $43.26 | $662.3K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 12 | $96.5M | 52.5% |
Sale(S) | 109 | $75.8M | 41.2% |
Payment(F) | 1 | $7.5M | 4.1% |
Exercise(M) | 78 | $3.4M | 1.8% |
Other(J) | 14 | $564.5K | 0.3% |
Award(A) | 5 | $75.2K | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insider activity at ANAPTYSBIO INC shows mixed signals across all time. While $96.5M in purchases indicates some executive confidence,$75.8M in sales balances the picture, resulting in a modest net flow of $20.7M.21 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Capital, Llc Ecor1, has transacted $102.3M during this period.